Inactive Instrument

Company Olainfarm AS Nasdaq Riga

OLF1R

LV0000100501

Pharmaceuticals

End-of-day quote Nasdaq Riga Other stock markets
- ^LVL	-

21-12-06	AS "AB CITY" completed the acquisition of an additional 49.19% stake in AS Olainfarm from a group of shareholders for €64.2 million.	CI
21-11-12	Olainfarm Board OKs AB City's Mandatory Share Buyback Offer	MT

Business description: Olainfarm AS

Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company's activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.

Sales by Activity: Olainfarm AS

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Manufacturing of Medicines	86.84M	75.65M
Retail Sale	25.67M	26.82M
Wholesale	17.55M	17.27M
Other Segments	12.67M	10.46M
Compression Products	12.45M	8.41M
Unallocated and Eliminated	-17.97M	-16.45M

See all business segments

Geographical breakdown of sales: Olainfarm AS

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Latvia	38.8M	39.18M
Russia	44.08M	28.02M
Belarus	15.16M	15.26M
Central Asia	11.15M	11.56M
Ukraine	10.71M	11.46M
EU Countries	10.62M	9.5M
Other Countries	4.6M	4.75M
Caucasus Countries	2.1M	2.44M

See all geographic segments

Executive Committee: Olainfarm AS

Manager	Title	Age	Since
Juris Hmelnickis CEO	Chief Executive Officer	46	2025-12-31
Janis Leimanis DFI	Director of Finance/CFO	56	-
Mikhail Skomorokhov CTO	Chief Tech/Sci/R&D Officer	-	2009-12-31
Vladimirs Krusinskis CTO	Chief Tech/Sci/R&D Officer	47	2017-06-11
Mihails Raizbergs CTO	Chief Tech/Sci/R&D Officer	-	2005-12-31

See OLAINFARM AS governance

Composition of the Board of Directors: Olainfarm AS

Director	Title	Age	Since
Andrejs Leibovics BRD	Director/Board Member	63	2021-06-18
Janis Buks CHM	Chairman	-	2022-08-31
Roberts Tavjevs BRD	Director/Board Member	-	-
Vadims Telica BRD	Director/Board Member	62	-
Sergejs Kornijenko BRD	Director/Board Member	-	-

Composition of the Board of Directors

Company details: Olainfarm AS

Olainfarm AS

Rupnicu iela 5

LV-2114, Olaine

+371 67 013 708

http://www.olpha.eu/

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+1.81%	+2.25%	+13.63%	+81.62%	48B
OTSUKA HOLDINGS CO., LTD.	-2.54%	+3.72%	+66.86%	+116.52%	36.89B
CIPLA LIMITED	+0.15%	+1.26%	-3.64%	+44.11%	12.37B
ZYDUS LIFESCIENCES LIMITED	+3.71%	+3.56%	+13.95%	+98.68%	11.95B
KRKA, D. D.	+0.39%	+0.58%	+32.90%	+120.94%	9.01B
GEDEON RICHTER	+0.66%	-0.57%	+19.74%	+46.69%	7.2B
ONO PHARMACEUTICAL CO., LTD.	+0.71%	+1.75%	+52.67%	-6.28%	7.05B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+9.99%	+32.94%	-15.50%	+25.64%	6.58B
GLENMARK PHARMACEUTICALS LIMITED	+0.68%	+2.63%	+20.79%	+240.34%	6.55B
Average	+1.73%	+4.24%	+22.38%	+85.36%	16.18B
Weighted average by Cap.	+0.84%	+3.35%	+28.07%	+89.74%